AtriCure, Inc.

Healthcare

NASDAQ:ATRC · NASDAQ Global Market

Market Cap $1.46B Beta 1.26 P/E (TTM) -295.5

$28.80 +3.52%

+$0.96 today

52W Low $25.36High $43.18

Vol 1.60M · Avg 0.77M

EPS (TTM) -$0.10Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-9.72%

Period High

$42.41

Period Low

$25.86

Latest

$28.80

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

10x Genomics, Inc.

NASDAQ:TXG

$4.48B

LeMaitre Vascular, Inc.

NASDAQ:LMAT

$2.14B

Select Medical Holdings Corporation

NYSE:SEM

$2.05B

NovoCure Limited

NASDAQ:NVCR

$1.70B

Immunocore Holdings plc

NASDAQ:IMCR

$1.46B

BioLife Solutions, Inc.

NASDAQ:BLFS

$1.26B

Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

$1.20B

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

$1.12B

Azenta, Inc.

NASDAQ:AZTA

$1.05B

QuidelOrtho Corporation

NASDAQ:QDEL

$899.10M

What is the latest ATRC filing?

The latest filing shown is SD dated May 27, 2026.

How many recent filings does ATRC have?

Intrinsic Alpha currently shows 20 recent filings for ATRC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.